New sleep drug shows promise for liver patients

NCT ID NCT07480096

Completed Symptom relief Sponsor: Indonesia University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a sleep medication called lemborexant in 82 adults with liver cirrhosis who had trouble sleeping. The drug works by blocking wakefulness signals in the brain. Researchers measured sleep quality and checked for side effects on the liver. The goal was to see if lemborexant is a safe and effective option for this group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: lemborexant
What this could lead to: If it works, this could offer a safer sleep medication for people with liver cirrhosis, improving their quality of life without harming the liver.
What could go wrong: This is a small, early-phase trial (82 participants). The results may not apply to all cirrhosis patients, and long-term safety is not yet known.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cirrhosis of liver Fibrosis hepatic encephalopathy insomnia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CIRRHOSIS HEPATIC ENCEPHALOPATHY INSOMNIA LIVER CIRRHOSIS SLEEP QUALITY

Contacts and locations

Locations

Hepatobiliary Division, Internal Medicine Department, Dr Cipto Mangunkusumo National General Hospital, Faculty of Medicine Universitas Indonesia, Jakarta

Jakarta, DKI Jakarta, 10430, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.